Health insurance benefits on 125 products containing Huahai’s Valsartan temporarily suspended
The health insurance benefits for 125 antihypertensive products which use Chinse ‘Valsartan’ have been suspended.
The Ministry of Health and Welfare(MOHW) Pharmaceutical Benefits Division informed the ‘Notification Alerts for Suspension of Health Insurance Benefits’ on the 9th.
Previously, the ...
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.